IRIS
FRIES, Walter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.487
EU - Europa 4.231
AS - Asia 1.267
OC - Oceania 10
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.004
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.474
SE - Svezia 1.196
IE - Irlanda 1.170
CN - Cina 662
SG - Singapore 531
UA - Ucraina 360
DE - Germania 339
IT - Italia 297
FR - Francia 287
GB - Regno Unito 222
FI - Finlandia 190
PL - Polonia 77
IN - India 34
RU - Federazione Russa 27
BE - Belgio 24
NL - Olanda 13
CA - Canada 11
VN - Vietnam 9
AT - Austria 8
AU - Australia 8
ID - Indonesia 8
KR - Corea 5
ES - Italia 4
JP - Giappone 4
CH - Svizzera 3
CL - Cile 3
EU - Europa 3
IL - Israele 3
IR - Iran 3
RO - Romania 3
BR - Brasile 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
AR - Argentina 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
HU - Ungheria 1
IQ - Iraq 1
LV - Lettonia 1
ME - Montenegro 1
MY - Malesia 1
NP - Nepal 1
RS - Serbia 1
SA - Arabia Saudita 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 10.004
Salva come PNG Salva come JPEG
Città #
Dublin 1.168
Chandler 953
Jacksonville 762
Nyköping 509
Singapore 423
Beijing 264
Ashburn 246
Princeton 220
Dearborn 191
Cambridge 183
Des Moines 173
Medford 143
Lancaster 117
Boardman 112
Ann Arbor 94
Messina 71
Woodbridge 69
Warsaw 64
Jinan 57
Wilmington 52
Bremen 50
Shenyang 49
San Mateo 42
Los Angeles 30
Seattle 29
Hebei 26
Tianjin 26
Zhengzhou 25
Ningbo 24
Brussels 23
Houston 21
Munich 21
Nanjing 21
Haikou 19
Hangzhou 18
Helsinki 17
Washington 16
Jiaxing 14
Changsha 13
Milan 13
Nanchang 13
Hyderabad 12
Taizhou 12
Rome 11
Pune 10
Falls Church 9
Fuzhou 9
Redwood City 9
Catania 8
Dong Ket 8
Jakarta 8
Kunming 8
Vienna 8
Guangzhou 7
Saint Petersburg 7
Augusta 6
Carini 6
Norwalk 6
Taiyuan 6
Hefei 5
Lanzhou 5
Milazzo 5
Mountain View 5
New York 5
Tappahannock 5
Amsterdam 4
Barcelona 4
Hanover 4
Lappeenranta 4
Leawood 4
London 4
Trecastagni 4
Turin 4
Vittoria 4
Albany 3
Auburn Hills 3
Belluno 3
Brisbane 3
Chicago 3
Clearwater 3
Ficarra 3
Islington 3
Jung-gu 3
Kemerovo 3
Mineo 3
Padova 3
Palermo 3
Riva 3
Salerno 3
Stockholm 3
The Dalles 3
Ardabil 2
Bari 2
Berlin 2
Brooklyn 2
Campobasso 2
Desio 2
Enna 2
Frankfurt am Main 2
Gurgaon 2
Totale 6.666
Salva come PNG Salva come JPEG
Nome #
Combined approach with biologics and surgery for entero-cutaneous fistulas in Crohn’s disease 106
Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature 92
Optical coherence tomography evaluation of ulcerative colitis: The patterns and the comparison with histology 84
Metacognitions and basic emotions in patients with irritable bowel syndrome and inflammatory bowel disease 83
A three year pilo study with 1,25 dihydroxyvitamin D, calcium and calcitonin for severe osteodystrophy in primary biliary cirrhosis 81
Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy. 81
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 76
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 75
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 75
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience 72
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 72
Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis. 71
IBD-associated bone loss: is inflammation the explanation? 70
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. 69
Early Post-Operative Endoscopic Recurrence in Crohn's Disease in an Italian Multicentric Cohort. 68
A protective effect of the synthetic coumarine derivative cloricromene on DNB-colitis in the rat. 68
Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease. 68
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 68
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. 67
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 66
Vitamin D and inflammatory bowel disease 66
Negative emotions in irritable bowel syndrome: which differences among IBS subtypes? 66
The aged gut in inflammatory bowel diseases. 66
Hepatocyte tight-junctional permeability is increased in rat experimental colitis. 65
Microradiographic anatomy of the explanted rat colon 65
Quality of life after proctocolectomy and ileo-anal anastomosis for severe ulcerative colitis 65
Oral beclomethasone diproprionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. 64
Age is a Risk Factor for Severe Infections and Mortality in Patients given Anti-Tumor Necrosis Factor Therapy for Inflammatory bowel disease. 64
Association between previously identified disease loci at chr12q15 and chr1p36 and UC in Italian population 64
Ileal tight junction (TJ) alterations associated with experimental colitis – a time course. 64
Bone metabolism in orthotopic liver transplantation: a prospective study 63
Gastric fundectomy in the rat - effects on mineral bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis 63
Guide to magnetic resonance in Crohn's disease: from common findings to the more rare complicances. 63
Le porfirie 62
Anti-TNF therapy in elderly people in IBD; an Italian multicentre survey 62
A “real life” experience of infliximab use for Crohn’s disease in southern Italy 62
Anti-TNF Therapy in Elderly People in IBD: An Italian Multicentre Survey. 62
Fecal calprotectin correlates with intestinal permeabilità (IP) in patients with Crohn’s disease. 62
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 62
OCT Performance in the Diagnosis of Ulcerative Colitis 61
Association Between Previously Identified Disease Loci At Chr12q15 and Chr1p36 and UC in Italian Population. 61
Thiopurine treatment in inflammatory bowel disease: response predictors, safety and withdrawal in follow-up. 60
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 60
Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. 59
Infliximab normalizes intestinal permeability in the short-term but not fecal calprotectin in Crohn’s disease 59
Thalidomide for refractory bleeding small intestinal Crohn’s disease– a case report 59
Hemophagocytic lymphohistiocytic (HLH) syndrome in IBD patients treated with thiopurines – a case series 59
Inflammatory Bowel Disease in the Elderly – Knowledge Gaps and Potential Directions in Research 59
GASTROINTESTINAL PERMEABILITY IS INCRISED IN SCLERODERMA PATIENTS 58
Gastric permeability of sucrose is increased in portal hypertensive gastropathy. 58
Therapy-related adverse events in Crohn’s disease (CD) – a comparison between thiopurines, infliximab and combined therapy. 58
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 58
Clinical significante of NOD2/CARD15 and TLR4 gene SNPs in inflammatory bowel disease 57
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 57
The Optical Coherence Tomography in Inflammatory Bowel Disease (IBD): Prospective Evaluation of 35 Patients 56
Hepatitis virus infections (HBV, HCV) in inflammatory bowel disease: A multicenter GISC study. 56
Osteopenia following total gastrectomy in the rat - state of mineral metabolism and bone histomorphometry 55
Clinical practice in the management of ulcerative colitis - an Italian survey 55
Analisi molecolare dei geni TLR4 e CARD15/NOD2 in pazienti affetti da malattie infiammatorie croniche intestinali: dati preliminari in una popolazione del sud Italia 55
Effects of anti COX-2, nabumetone and aspirin on gastric and intestinal permeability on healthy volunteers 55
Thiopurines in the treatment of inflammatory bowel diseases – a single centre experience. 55
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 55
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 54
Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach 54
Treatment of life threatening type I refractory celiac disease with long term infliximab 53
Gastric permeability to sucrose is increased in portal hypertensive gastropathy 53
Experimental colitis increases small intestine permeability in the rat 53
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 53
Contenuti metacognitivi e alessitimia in un gruppo di soggetti con disturbi gastrointestinali. Uno studio esplorativo 53
Cytomegalovirus complicating Inflammatory Bowel Disease: Useful Remarks. 53
Turnover osseo e sistema osteoprotegerina/RANKL nell'osteodistrofia epatica 52
TNF-alpha inhibition prevents early tight junction rearrangement and apoptosis of ileal enterocytes in experimental colitis. 52
Effect of experimental colitis on bone metabolism in the rat 51
TNF-ALPHA INHIBITION PREVENTS EARLY TIGHT JUNCTION REARRANGEMENT AND APOPTOSIS OF ILEAL ENTEROCYTES IN EXPERIMENTAL COLITIS. 51
A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat 51
Predicting response to thiopurines – a single centre experience. 51
A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 51
The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat 50
Infliximab and etanercept are equally effective in reducing enterocyte apoptosis in experimental colitis. 50
Intestinal permeability and genetic determinants in patients, first degree relatives and controls in a high incidence area of Crohn’s disease. 50
Celiac disease (CD) in inflammatory bowel diseases (IBD): a preliminary result of a prevalence study. 50
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice. 50
Adalimumab In Active Ulcerative Colitis: A “Real-Life” Observational Study on behalf of the Italian Group for the study of Inflammatory Bowel Disease. 50
Bone density and calcium metabolism in patients with long standing, quiescent Crohn's disease 49
Infliximab: effetto su nutrizione e permeabilità intestinale 49
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 49
Extra-gastric effects of highly selective vagotomy. Bone and mineral metabolism in the rat. 49
Safety of a (H1N1)V Vaccine in patients with inflammatory bowel disease treated with immunomodulators and biologicals 49
Mucosal Immunology and Probiotics. 49
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study 49
Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease 49
Omega-3 polyunsaturated fatty acids reduce bone loss in experimental colitis. 48
Use of alternative and complementary medicine in Italian patients with Inflammatory Bowel Disease 48
Mast cells mediate stress-induced loss of ileal tight junction (TJ)-permselectivity in the rat. 48
Efficacy and safety of long-term infliximab use for Crohn’s disease in Southern Italy. 47
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 47
Vagus-sparing fundectomy in the rat - development of osteopenia, relationship to urinary phosphate and net acid secretion, serum gastrin and vitamin D 46
Changing approach to gastroenteropancreatic tumours. Case report of a gastrinoma metastasis localised by somatostatin-receptor scintigraphy 46
Oral propranolol decreases intestinal permeability in patients with cirrhosis: another protective mechanism against bleeding? 46
Dysfunctional metacognitive beliefs and gastrointestinal disorders. Beyond an ‘organic’/‘functional’ categorization in the clinical practice 46
Totale 5.946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.163 0 0 0 0 24 214 214 221 42 191 232 25
2020/20211.432 157 25 329 100 110 166 57 116 23 156 107 86
2021/20221.422 8 191 30 42 45 15 62 46 15 337 196 435
2022/20233.433 304 280 156 303 288 323 39 178 1.418 17 91 36
2023/2024798 70 117 88 133 89 103 21 30 2 69 8 68
2024/2025712 64 56 129 233 230 0 0 0 0 0 0 0
Totale 10.388